We are live on ! Find out more
ALIM

Alimera Sciences
ALIM

Delisted

ALIM was delisted on the 13th of September, 2024.

Back to rankings

18 hedge funds and large institutions have $8.49M invested in Alimera Sciences in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less capital invested

Capital invested by funds: $9.09M → $8.49M (-$602K)

14% less funds holding

Funds holding: 21 → 18 (-3)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
18
Holders Change
-3
Holders Change %
-14.29%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$1.22M
2
Morgan Stanley
Morgan Stanley
New York
+$651K
3
Citigroup
Citigroup
New York
+$9.54K

Top Sellers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
-$2.55M
2
WVP
Worth Venture Partners
New Jersey
-$636K
3
Millennium Management
Millennium Management
New York
-$65K
4
Renaissance Technologies
Renaissance Technologies
New York
-$17.5K
5
JP Morgan Chase
JP Morgan Chase
New York
-$6.48K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$3.15M +$651K +133,778 +31%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$1.4M +$1.22M +250,000 New
PAI
3
Palo Alto Investors
California
$1.13M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$815K -$5.99K -1,230 -0.8%
Renaissance Technologies
5
Renaissance Technologies
New York
$699K -$17.5K -3,600 -3%
CCPM
6
Cooper Creek Partners Management
New York
$438K – – –
BlackRock
7
BlackRock
New York
$165K -$3.55K -729 -2%
Deutsche Bank
8
Deutsche Bank
Germany
$157K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$140K – – –
PCM
10
Perritt Capital Management
Illinois
$112K – – –
Acadian Asset Management
11
Acadian Asset Management
Massachusetts
$108K – – –
BCM
12
Bridgeway Capital Management
Texas
$102K – – –
OIA
13
Optimum Investment Advisors
Illinois
$45K – – –
JP Morgan Chase
14
JP Morgan Chase
New York
$18K -$6.48K -1,330 -29%
Citigroup
15
Citigroup
New York
$11K +$9.54K +1,959 New
AA
16
Ancora Advisors
Ohio
$2K – – –
ACM
17
AIGH Capital Management
Maryland
– -$2.55M -497,639 Closed
WVP
18
Worth Venture Partners
New Jersey
– -$636K -123,947 Closed
Millennium Management
19
Millennium Management
New York
– -$65K -12,716 Closed
TRCT
20
Tower Research Capital (TRC)
New York
– -$1K -200 Closed

ALIM Hedge Fund Activity: Q1 2022 in Review

18 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q1 2022, worth a combined $8.49M — down 6.6% from $9.09M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ALIM and 2 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 1 added.

The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $1.22M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $2.55M sold.

  • 18 institutional investors held Alimera Sciences (ALIM) as of Q1 2022, down from 21 in Q4 2021.
  • Funds reported $8.49M of Alimera Sciences stock for Q1 2022, down 6.6% quarter-over-quarter.
  • 2 funds opened new Alimera Sciences positions in Q1 2022 and 5 closed out, a net change of -3 holders.
  • The largest Alimera Sciences buyer in Q1 2022 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $1.22M added.
  • The largest Alimera Sciences seller in Q1 2022 was AIGH Capital Management, an estimated $2.55M sold.

Based on aggregated 13F filings for Q1 2022.